𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastoma

✍ Scribed by V Combaret; N Gross; C Lasset; D Frappaz; C Beretta-Brognara; T Philip; D Beck; M.C Favrot


Book ID
117663959
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
113 KB
Volume
33
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Expression of P27KIP1 is prognostic and
✍ Eckhard Bergmann; Michael Wanzel; Axel Weber; Inhee Shin; Holger Christiansen; M πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 366 KB πŸ‘ 2 views

Amplification of the MYCN gene is significantly associated with an unfavorable prognosis and rapid progression in human neuroblastoma tumors. One potential mechanism by which MYCN may cause these effects is by deregulating cell proliferation. Tissue culture experiments support a model in which MYC g

Co-amplification and concomitant high le
✍ Chitra F. Manohar; Helen R. Salwen; Garrett M. Brodeur; Dr. Susan L. Cohn πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 670 KB

MYCN gene amplification is strongly correlated with poor prognosis in neuroblastoma (NB), the second most common solid pediatric tumor. However, increased MYCN expression seen in tumors that lack MYCN amplification does not correlate with aggressive clinical behavior. Whereas the MYCN gene spans onl

Hypermethylation-mediated regulation of
✍ Pu Yan; Annick MΓΌhlethaler; Katia Balmas Bourloud; Maja Nenadov Beck; Nicole Gro πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 376 KB

## Abstract The CD44 adhesion receptor is silenced in highly malignant neuroblastomas (NBs) with __MYCN__ amplification. Because its functional expression is associated with decreased tumorigenic properties, __CD44__ behaves as a tumor suppressor gene in NB and other cancers. Given that the precise